These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6875857)

  • 1. Differential sensitivity of hypothalamic norepinephrine and striatal dopamine to catecholamine-depleting agents.
    Takimoto GS; Stittsworth JD; Bianchi BR; Stephens JK
    J Pharmacol Exp Ther; 1983 Aug; 226(2):432-9. PubMed ID: 6875857
    [No Abstract]   [Full Text] [Related]  

  • 2. Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine.
    Horn AS; Snyder SH
    J Pharmacol Exp Ther; 1972 Mar; 180(3):523-30. PubMed ID: 5012779
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of desmethylimipramine on the release of (3H)norepinephrine induced by various agents in hypothalamic synaptosomes.
    Raiteri M; del Carmine R; Bertollini A
    Mol Pharmacol; 1977 Jul; 13(4):746-58. PubMed ID: 887077
    [No Abstract]   [Full Text] [Related]  

  • 4. Lability in storage of 3H-dopamine and 3H-norepinephrine in crude synaptosome (P2) and vesicle-associated fractions of rat brain.
    Bianchi BR; Takimoto GS
    Life Sci; 1984 Feb; 34(7):607-15. PubMed ID: 6700371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of bromocriptine on 3H-dopamine uptake in hypothalamic synaptosomes of intact and adrenalectomized rats].
    Iatsyk MI
    Vopr Med Khim; 1986; 32(5):60-2. PubMed ID: 3776119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging effects on hypothalamic dopamine and norepinephrine content in the male rat.
    Miller AE; Shaar CJ; Riegle GD
    Exp Aging Res; 1976 Sep; 2(5):475-80. PubMed ID: 1017462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of the antidepressant activity of the enantiomers of bupropion.
    Musso DL; Mehta NB; Soroko FE; Ferris RM; Hollingsworth EB; Kenney BT
    Chirality; 1993; 5(7):495-500. PubMed ID: 8240925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential interactions of phencyclidine with tetrabenazine and reserpine affecting intraneuronal dopamine.
    Bagchi SP
    Biochem Pharmacol; 1983 Oct; 32(19):2851-6. PubMed ID: 6626259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amantadine and catecholamine uptake.
    Herblin WF
    Biochem Pharmacol; 1972 Jul; 21(14):1993-5. PubMed ID: 4649347
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes.
    Poddar MK; Dewey WL
    J Pharmacol Exp Ther; 1980 Jul; 214(1):63-7. PubMed ID: 7391971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium attenuates dopamine depleting effects of reserpine and tetrabenazine but not that of alpha methyl-p-tyrosine.
    Reches A; Hassan MN; Jackson VR; Fahn S
    Life Sci; 1983 Jul; 33(2):157-60. PubMed ID: 6865653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A structure-activity study of the transport sites for the hypothalamic and striatal catecholamine uptake systems. Similarities and differences.
    Eckhardt SB; Maxwell RA; Ferris RM
    Mol Pharmacol; 1982 Mar; 21(2):374-9. PubMed ID: 7099141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of relationship between the epiphysis and the sympathetico-adrenal system in the depressogenic effect of reserpine].
    Arushanian EB; El'bekian KS
    Biull Eksp Biol Med; 1996 Jun; 121(6):651-3. PubMed ID: 9035758
    [No Abstract]   [Full Text] [Related]  

  • 14. Transmitter-dependent changes of equilibrium characteristics of catecholamine synaptosomes in sucrose density gradients.
    Pycock C; Jonsson G
    Med Biol; 1974 Aug; 52(4):260-8. PubMed ID: 4371596
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the administration of catecholamine-depleting drugs on the thyroid function of the rat.
    Coleoni AH
    Pharmacology; 1972; 8(4):300-10. PubMed ID: 4657978
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensitivities of the brains of infant and adult rats to the catecholamine-depleting actions of reserpine and tetrabenazine.
    Kulkarni AS; Shideman FE
    J Pharmacol Exp Ther; 1966 Sep; 153(3):428-33. PubMed ID: 5922320
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of narcotic analgesic drugs on the uptake and release of neurotransmitters in isolated synaptosomes.
    Clouet DH; Williams N
    J Pharmacol Exp Ther; 1974 Feb; 188(2):419-28. PubMed ID: 4811303
    [No Abstract]   [Full Text] [Related]  

  • 18. Estradiol increases catecholamine levels in the hypothalamus of ovariectomized rats during the dark-phase.
    Alfinito PD; Chen X; Mastroeni R; Pawlyk AC; Deecher DC
    Eur J Pharmacol; 2009 Aug; 616(1-3):334-9. PubMed ID: 19576879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide YY (3 -36) inhibits dopamine and norepinephrine release in the hypothalamus.
    Brunetti L; Orlando G; Ferrante C; Chiavaroli A; Vacca M
    Eur J Pharmacol; 2005 Sep; 519(1-2):48-51. PubMed ID: 16095590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic catecholamine systems in genetically obese mice (obob): decreased sensitivity to reserpine treatment.
    Oltmans GA; Olsauskas R; Comaty JE
    Neuropharmacology; 1980 Jan; 19(1):25-33. PubMed ID: 7360328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.